Cargando…

Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms

Impairment of health after overcoming the acute phase of COVID-19 is being observed more and more frequently. Here different symptoms of neurological and/or cardiological origin have been reported. With symptoms, which are very similar to the ones reported but are not caused by SARS-CoV-2, the occur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallukat, Gerd, Hohberger, Bettina, Wenzel, Katrin, Fürst, Julia, Schulze-Rothe, Sarah, Wallukat, Anne, Hönicke, Anne-Sophie, Müller, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049853/ https://www.ncbi.nlm.nih.gov/pubmed/33880442 http://dx.doi.org/10.1016/j.jtauto.2021.100100

Ejemplares similares

Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology
por: Wenzel, Katrin, et al.
Publicado: (2018)

Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors—a requisite for correct data evaluation
por: Haberland, Annekathrin, et al.
Publicado: (2018)

Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy
por: Wenzel, Katrin, et al.
Publicado: (2017)

A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
por: Becker, Niels-Peter, et al.
Publicado: (2020)

Animals Experimentally Infected with SARS-CoV-2 Generate Functional Autoantibodies against G-Protein-Coupled Receptors
por: Wallukat, Gerd, et al.
Publicado: (2023)

Functional autoantibodies in patients with different forms of dementia
por: Wallukat, Gerd, et al.
Publicado: (2018)

Correction: Functional autoantibodies in patients with different forms of dementia
por: Wallukat, Gerd, et al.
Publicado: (2018)

Are Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy?
por: Haberland, Annekathrin, et al.
Publicado: (2013)

Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
por: Hohberger, Bettina, et al.
Publicado: (2021)

Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance
por: Hohberger, Bettina, et al.
Publicado: (2022)

Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy
por: Wess, Gerhard, et al.
Publicado: (2019)

Inhibitory and Agonistic Autoantibodies Directed Against the β(2)-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2021)

Agonistic β2-Adrenergic Receptor Autoantibodies Characterize the Aqueous Humor of Patients With Primary and Secondary Open-Angle Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2021)

Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation
por: Szewczykowski, Charlotte, et al.
Publicado: (2022)

Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
por: Hohberger, Bettina, et al.
Publicado: (2021)

C-Reactive Protein (CRP) Blocks the Desensitization of Agonistic Stimulated G Protein Coupled Receptors (GPCRs) in Neonatal Rat Cardiomyocytes
por: Wallukat, Gerd, et al.
Publicado: (2022)

Suppression of β1-Adrenoceptor Autoantibodies is Involved in the Antiarrhythmic Effects of Omega-3 Fatty Acids in Male and Female Hypertensive Rats
por: Szeiffova Bacova, Barbara, et al.
Publicado: (2020)

Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2019)

Functional antibodies against G-protein coupled receptors in Beagle dogs infected with two different strains of Trypanosoma cruzi
por: Wallukat, Gerd, et al.
Publicado: (2022)

The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
por: Werner, Sabine, et al.
Publicado: (2020)

Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma
por: Jünemann, Anselm, et al.
Publicado: (2018)

Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer
por: Wallukat, Gerd, et al.
Publicado: (2020)

Potential Relevance of α(1)-Adrenergic Receptor Autoantibodies in Refractory Hypertension
por: Wenzel, Katrin, et al.
Publicado: (2008)

Immunoadsorption for Treatment of Patients with Suspected Alzheimer Dementia and Agonistic Autoantibodies against Alpha1a-Adrenoceptor—Rationale and Design of the IMAD Pilot Study
por: Stracke, Sylvia, et al.
Publicado: (2020)

β(1)-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes
por: Park, Misun, et al.
Publicado: (2017)

α(1A)-Adrenergic Receptor-Directed Autoimmunity Induces Left Ventricular Damage and Diastolic Dysfunction in Rats
por: Wenzel, Katrin, et al.
Publicado: (2010)

Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue
por: Schlick, Sarah, et al.
Publicado: (2022)

Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling—Additional Information About TLR9 Involvement
por: Haberland, Annekathrin, et al.
Publicado: (2019)

Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome
por: Pitarokoili, Kalliopi, et al.
Publicado: (2021)

Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
por: L’Huillier, Arnaud G., et al.
Publicado: (2022)

Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome
por: Bertin, Daniel, et al.
Publicado: (2021)

Physical phenotype of blood cells is altered in COVID-19
por: Kubánková, Markéta, et al.
Publicado: (2021)

Psychiatric Symptoms in Acute and Persisting Forms of COVID-19 Associated with Neural Autoantibodies
por: Hansen, Niels
Publicado: (2023)

Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Freitag, Helma, et al.
Publicado: (2021)

When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis
por: Akbarzadeh, Reza, et al.
Publicado: (2023)

B Cells and Autoantibodies in Multiple Sclerosis
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G‐Protein Coupled Receptor Autoantibodies
por: Gunning, William T., et al.
Publicado: (2019)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
por: Müller, Ralf, et al.
Publicado: (2010)

Endophthalmitis: Epidemiology, Causing Agents, Therapy and Visual Outcome with Special Focus on Glaucoma Patients
por: Vorbeck, Julia, et al.
Publicado: (2022)

Die „DOG 2020 online“ – erstmals im von-Graefe-Jahr
por: Hohberger, Bettina
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_41s4rdck1dp0e32qlivdho6ntd